Senate committee threatens to force drugmaker testimony by Tina Reed Wednesday, January 30, 2019 Republicans and Democrats found an issue they could agree on this week: They are particularly unhappy with drugmakers.
Experts: Drug prices likely to be center stage in 2020 election by Paige Minemyer Tuesday, November 13, 2018 HHS’ drug pricing plans are meant to signal to the healthcare industry—and voters—that it's serious on this issue, experts say.
Why don't we control exorbitant drug prices? by Jay Hancock, Kaiser Health News Monday, September 25, 2017 From Kaiser Health News: Momentum to address prescription drug costs has been lost amid rancorous debates over replacing the Affordable Care Act.
Drug rebates reward industry players—and often hurt patients by Sarah Jane Tribble, Kaiser Health News Wednesday, May 31, 2017 From Kaiser Health News: A new JAMA study examines how drug rebates can direct money to middlemen and force Medicare patients to cough up more money.
